CACI Stock Analysis: CACI International | NYSE
Information Technology Services | NYSE, USA | Market Cap: 13.506m USD | 12M Return: 9.4% | US1271903049 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 153M
EPS Trend: 98.6%
Qual. Beats: 2
Rev. Trend: 99.6%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
CACI International Inc is a U.S.-headquartered technology and services provider that delivers expertise and solutions across command, control, communications, and intelligence (C4I), signals intelligence, electronic warfare, cyber operations, secure enterprise IT, and space-related capabilities. Founded in 1962 and based in Reston, Virginia, the company serves national security customers across the intelligence, defense, and federal civilian sectors, with operations in the United States, the United Kingdom, continental Europe, and other international markets. Its offerings span specialized hardware and software, mission and engineering support services, and proprietary data products for both government and commercial clients.
As a large-cap stock in the IT Consulting & Other Services sub-industry, CACI operates primarily as a government contractor, with revenue largely tied to U.S. federal and allied defense and intelligence spending. The companys business model is centered on long-term, mission-critical contracts with government agencies, supported by a workforce that blends engineering, technical, and operational expertise.
- Defense budget growth boosts intelligence and electronic warfare revenue
- Acquisitions expand technology portfolio and drive margin expansion
- Federal contract competition pressures organic growth and margins
| Net Income: 541.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -0.54 > 1.0 |
| NWC/Revenue: 9.48% < 20% (prev 7.38%; Δ 2.09% < -1%) |
| CFO/TA 0.07 > 3% & CFO 877.0m > Net Income 541.4m |
| Net Debt (5.45b) to EBITDA (1.15b): 4.72 < 3 |
| Current Ratio: 1.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (22.3m) vs 12m ago 0.68% < -2% |
| Gross Margin: 21.60% > 18% (prev 8.99%; Δ 12.60% > 0.5%) |
| Asset Turnover: 94.47% > 50% (prev 101.8%; Δ -7.30% > 0%) |
| Interest Coverage Ratio: 3.64 > 6 (EBIT TTM 883.0m / Interest Expense TTM 242.5m) |
| A: 0.08 (Total Current Assets 2.43b - Total Current Liabilities 1.51b) / Total Assets 11.9b |
| B: 0.46 (Retained Earnings 5.53b / Total Assets 11.9b) |
| C: 0.09 (EBIT TTM 883.0m / Avg Total Assets 10.3b) |
| D: 0.63 (Book Value of Equity 4.63b / Total Liabilities 7.32b) |
| Altman-Z'' = 3.25 = A |
| DSRI: 1.10 (Receivables 1.72b/1.43b, Revenue 9.75b/8.86b) |
| GMI: 0.42 (GM 8.99% / 21.60%) |
| AQI: 1.02 (AQ_t 0.73 / AQ_t-1 0.72) |
| SGI: 1.10 (Revenue 9.75b / 8.86b) |
| TATA: -0.03 (NI 541.4m - CFO 877.0m) / TA 11.9b) |
| Beneish M = -3.40 (Cap -4..+1) = AA |
As of November 11, 2026, the stock is trading at USD 647.57 with a total of 290,254 shares traded. Over the past week, the price has changed by -4.78%, over one month by +5.41%, over three months by -0.10% and over the past year by +9.41%.
Current recommended Stop Loss: 614.90 (which is 5% or 1.2 ATR below the current price).
CACI International has received a consensus analysts rating of 4.53. Therefore, it is recommended to buy CACI.
- StrongBuy: 13
- Buy: 1
- Hold: 2
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 747.2 | 15.4% |
P/E Trailing = 25.0887
P/E Forward = 17.8253
P/S = 1.3846
P/B = 2.9192
P/EG = 514.2342
Revenue TTM = 9.75b USD
EBIT TTM = 883.0m USD
EBITDA TTM = 1.15b USD
Long Term Debt = 4.79b USD (from longTermDebt, last quarter)
Short Term Debt = 46.8m USD (from shortTermDebt, last quarter)
Debt = 5.73b USD (from shortLongTermDebtTotal, last quarter) + Leases 447.2m
Net Debt = 5.45b USD (calculated: Debt 5.73b - CCE 279.4m)
Enterprise Value = 19.0b USD (13.5b + Debt 5.73b - CCE 279.4m)
Interest Coverage Ratio = 3.64 (Ebit TTM 883.0m / Interest Expense TTM 242.5m)
EV/FCF = 24.43x (Enterprise Value 19.0b / FCF TTM 776.0m)
FCF Yield = 4.09% (FCF TTM 776.0m / Enterprise Value 19.0b)
FCF Margin = 7.95% (FCF TTM 776.0m / Revenue TTM 9.75b)
Net Margin = 5.55% (Net Income TTM 541.4m / Revenue TTM 9.75b)
Gross Margin = 21.60% ((Revenue TTM 9.75b - Cost of Revenue TTM 7.65b) / Revenue TTM)
Gross Margin QoQ = 10.00% (prev 33.72%)
Tobins Q-Ratio = 1.59 (Enterprise Value 19.0b / Total Assets 11.9b)
Interest Expense / Debt = 4.23% (Interest Expense 242.5m / Debt 5.73b)
Taxrate = 24.02% (171.2m / 712.5m)
NOPAT = 670.9m (EBIT 883.0m * (1 - 24.02%))
Current Ratio = 1.61 (Total Current Assets 2.43b / Total Current Liabilities 1.51b)
Debt / Equity = 1.24 (Debt 5.73b / totalStockholderEquity, last quarter 4.63b)
Debt / EBITDA = 4.72 (Net Debt 5.45b / EBITDA 1.15b)
Debt / FCF = 7.03 (Net Debt 5.45b / FCF TTM 776.0m)
Total Stockholder Equity = 4.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.24% (Net Income 541.4m / Total Assets 11.9b)
RoE = 12.37% (Net Income TTM 541.4m / Total Stockholder Equity 4.38b)
RoCE = 9.63% (EBIT 883.0m / Capital Employed (Equity 4.38b + L.T.Debt 4.79b))
RoIC = 6.57% (NOPAT 670.9m / Invested Capital 10.2b)
WACC = 5.72% (E(13.5b)/V(19.2b) * Re(6.78%) + D(5.73b)/V(19.2b) * Rd(4.23%) * (1-Tc(0.24)))
Discount Rate = 6.78% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -69.41 | Cagr: -0.38%
[DCF] Terminal Value 77.97% ; FCFF base≈710.5m ; Y1≈814.5m ; Y5≈1.20b
[DCF] Fair Price = 569.5 (EV 18.0b - Net Debt 5.45b = Equity 12.6b / Shares 22.1m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.58 | EPS CAGR: 19.73% | SUE: 2.15 | # QB: 2
Revenue Correlation: 99.61 | Revenue CAGR: 11.92% | SUE: -0.64 | # QB: 0
EPS current Quarter (2026-12-31): EPS=7.37 | Chg30d=-1.53% | Revisions=-15% | Analysts=13
EPS next Quarter (2027-03-31): EPS=8.78 | Chg30d=-1.72% | Revisions=-21% | Analysts=13
EPS current Year (2027-06-30): EPS=33.90 | Chg30d=+0.66% | Revisions=+40% | GrowthEPS=+13.7% | GrowthRev=+13.0%
EPS next Year (2028-06-30): EPS=38.35 | Chg30d=+1.79% | Revisions=+47% | GrowthEPS=+13.1% | GrowthRev=+6.6%
[Analyst] Revisions Ratio: +18% (up=28, down=19)